Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ADPT
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 11,466 | $28.93 | $331.7K Sale | Form 4 ↗ |
| Nov 12, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 11,881 | $29.40 | $349.3K Sale | Form 4 ↗ |
| Nov 11, 2026 | Susan Bobulsky Chief Commercial Officer, MRD | ADPT Adaptive Biotechnologies Corporation | Sale | 1,875 | $32.00 | $60.0K Sale | Form 4 ↗ |
| Nov 11, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 6,898 | $31.22 | $215.4K Sale | Form 4 ↗ |
| Nov 11, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 4,983 | $30.29 | $150.9K Sale | Form 4 ↗ |
| Nov 10, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 1,900 | $30.41 | $57.8K Sale | Form 4 ↗ |
| Nov 10, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 9,981 | $29.35 | $292.9K Sale | Form 4 ↗ |
| Nov 9, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 2,400 | $30.58 | $73.4K Sale | Form 4 ↗ |
| Nov 9, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 8,381 | $30.15 | $252.7K Sale | Form 4 ↗ |
| Nov 9, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 1,100 | $28.87 | $31.8K Sale | Form 4 ↗ |
| Nov 6, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 3,481 | $27.88 | $97.1K Sale | Form 4 ↗ |
| Nov 6, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 8,400 | $27.32 | $229.5K Sale | Form 4 ↗ |
| Nov 5, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 500 | $27.70 | $13.8K Sale | Form 4 ↗ |
| Nov 5, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 5,455 | $26.88 | $146.6K Sale | Form 4 ↗ |
| Nov 5, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 5,926 | $26.10 | $154.7K Sale | Form 4 ↗ |
| Nov 4, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 7,881 | $26.60 | $209.6K Sale | Form 4 ↗ |
| Nov 4, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 4,000 | $25.78 | $103.1K Sale | Form 4 ↗ |
| Nov 3, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 11,881 | $25.98 | $308.7K Sale | Form 4 ↗ |
| Nov 2, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 2,585 | $26.34 | $68.1K Sale | Form 4 ↗ |
| Nov 2, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 9,296 | $25.23 | $234.5K Sale | Form 4 ↗ |
| Oct 30, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 2,395 | $27.45 | $65.7K Sale | Form 4 ↗ |
| Oct 30, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 9,486 | $26.55 | $251.9K Sale | Form 4 ↗ |
| Oct 29, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 11,881 | $28.27 | $335.9K Sale | Form 4 ↗ |
| Oct 28, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 200 | $28.90 | $5,780 Sale | Form 4 ↗ |
| Oct 28, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 11,681 | $28.44 | $332.2K Sale | Form 4 ↗ |
| Oct 27, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 8,881 | $27.53 | $244.5K Sale | Form 4 ↗ |
| Oct 27, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 3,000 | $26.58 | $79.7K Sale | Form 4 ↗ |
| Oct 26, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 3,378 | $26.30 | $88.8K Sale | Form 4 ↗ |
| Oct 26, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 8,503 | $25.94 | $220.6K Sale | Form 4 ↗ |
| Oct 23, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 7,381 | $25.28 | $186.6K Sale | Form 4 ↗ |
| Oct 23, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 4,500 | $24.50 | $110.3K Sale | Form 4 ↗ |
| Oct 22, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 1,700 | $25.29 | $43.0K Sale | Form 4 ↗ |
| Oct 22, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 10,181 | $24.38 | $248.2K Sale | Form 4 ↗ |
| Oct 21, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 5,882 | $25.57 | $150.4K Sale | Form 4 ↗ |
| Oct 21, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 5,999 | $25.25 | $151.5K Sale | Form 4 ↗ |
| Oct 20, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 100 | $24.85 | $2,485 Sale | Form 4 ↗ |
| Oct 20, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 11,781 | $24.53 | $289.0K Sale | Form 4 ↗ |
| Oct 19, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 11,881 | $24.05 | $285.7K Sale | Form 4 ↗ |
| Oct 16, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 300 | $25.45 | $7,635 Sale | Form 4 ↗ |
| Oct 16, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 11,581 | $24.21 | $280.4K Sale | Form 4 ↗ |
| Oct 15, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 11,881 | $25.61 | $304.3K Sale | Form 4 ↗ |
| Oct 14, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 5,100 | $25.82 | $131.7K Sale | Form 4 ↗ |
| Oct 14, 2026 | Julie Rubinstein President and COO | ADPT Adaptive Biotechnologies Corporation | Sale | 6,781 | $25.57 | $173.4K Sale | Form 4 ↗ |
| Sep 16, 2026 | Francis Lo Chief People Officer | ADPT Adaptive Biotechnologies Corporation | Sale | 7,869 | $28.57 | $224.8K Sale | Form 4 ↗ |
| Sep 16, 2026 | Francis Lo Chief People Officer | ADPT Adaptive Biotechnologies Corporation | Sale | 107,537 | $28.02 | $3.0M Sale | Form 4 ↗ |
| Sep 15, 2026 | Susan Bobulsky Chief Commercial Officer, MRD | ADPT Adaptive Biotechnologies Corporation | Sale | 1,195 | $27.00 | $32.3K Sale | Form 4 ↗ |
| Aug 26, 2026 | Katey Einterz Owen Director | ADPT Adaptive Biotechnologies Corporation | Sale | 9,615 | $26.00 | $250.0K Sale | Form 4 ↗ |
| Aug 18, 2026 | Chad M. Robins CEO and Chairman, Director | ADPT Adaptive Biotechnologies Corporation | Sale | 204 | $25.14 | $5,129 Sale | Form 4 ↗ |
| Aug 18, 2026 | Chad M. Robins CEO and Chairman, Director | ADPT Adaptive Biotechnologies Corporation | Sale | 278,472 | $24.48 | $6.8M Sale | Form 4 ↗ |
| Aug 18, 2026 | Robert Hershberg Director | ADPT Adaptive Biotechnologies Corporation | Sale | 15,664 | $24.41 | $382.4K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:19 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances